Chattem responds to CARU
This article was originally published in The Rose Sheet
Executive Summary
Chattem agrees to pull TV spot for pHisoderm Clear Confidence Clear Swabfrom children's programming in response to ad review by the Children's Advertising Review Unit, the Council of Better Business Bureaus division says. Chattem did not intend for commercial to air during TV shows directed to young children, and will try to ensure future commercials of this nature do not run during children's programs, CARU states. In a recent inquiry, CARU pointed out its guidelines recommend against advertising medication to children (1"The Rose Sheet" May 19, 2003, p. 5)...
You may also be interested in...
J&J’s Neutrogena, Chattem’s Phisoderm Ads Reviewed By CBBB
Johnson & Johnson agreed to permanently discontinue a TV ad for Neutrogena Deep Clean Gentle Scrub comparing the product's exfoliating properties to competitor formulas following a review by the National Advertising Division of the Council of Better Business Bureaus, according to NAD
‘Unbalanced’ EU HTA Timelines Exacerbated By Rare Disease & Cancer Drugs
As it stands, drugmakers will have just 90 days to prepare their dossiers for EU-wide joint clinical assessments under the new Health Technology Assessment Regulation. Market access experts from EFPIA tell the Pink Sheet that this short deadline could delay patient access to complex medicines, such as innovative cancer drugs.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.